U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
158401158401Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in IndiaCompletedNo Results AvailableVisceral Leishmaniasis|Post-kala-azar Dermal LeishmaniasisBiological: Leish-111f + MPL-SE Adjuvanthttps://ClinicalTrials.gov/show/NCT00486382
158402158402SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days StudyCompletedNo Results AvailableOsteoarthritisDrug: Oral salmon calcitoninhttps://ClinicalTrials.gov/show/NCT00486369
158403158403Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNo Results AvailableExtrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastric Cancer|Liver Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: capecitabine|Drug: carboplatin|Drug: epirubicin hydrochloride|Genetic: microarray analysis|Genetic: polymorphism analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00486356
158404158404Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICSTerminatedNo Results AvailableAsthmaDrug: Zileuton CR|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00486343
158405158405Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/RitonavirCompletedHas ResultsHIV InfectionsDrug: Buprenorphine, Tipranavir and ritonavirhttps://ClinicalTrials.gov/show/NCT00486330
158406158406Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With OsteoarthritisCompletedNo Results AvailableOsteoarthritisDrug: Oral salmon calcitonin, salmon calcitonin nasal sprayhttps://ClinicalTrials.gov/show/NCT00486317
158407158407Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation TherapyCompletedNo Results AvailableCachexia|Head and Neck Cancer|Weight ChangesOther: ADD|Other: Placebohttps://ClinicalTrials.gov/show/NCT00486304
158408158408Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese DiabeticsCompletedHas ResultsType 2 Diabetes MellitusDrug: VI-0521|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00486291
158409158409Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedHas ResultsCongenital Bleeding Disorder|Haemophilia A|Haemophilia BDrug: eptacog alfa (activated)|Drug: vatreptacog alfa (activated)|Drug: vatreptacog alfa (activated)|Drug: vatreptacog alfa (activated)|Drug: vatreptacog alfa (activated)|Drug: vatreptacog alfa (activated)https://ClinicalTrials.gov/show/NCT00486278
158410158410Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)TerminatedHas ResultsAcute Myelogenous LeukemiaDrug: AZD4877https://ClinicalTrials.gov/show/NCT00486265
158411158411Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®CompletedHas ResultsGlaucoma,Open-Angle|Ocular HypertensionOther: Observationalhttps://ClinicalTrials.gov/show/NCT00486252
158412158412Emotional Processing and Memory Evaluation in Epilepsy PatientsRecruitingNo Results AvailableEpilepsyBehavioral: neuropsychological evaluationhttps://ClinicalTrials.gov/show/NCT00486239
158413158413The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery SystemCompletedHas ResultsIntracranial AneurysmDevice: Vascular Reconstruction Devicehttps://ClinicalTrials.gov/show/NCT00486226
158414158414Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With CancerTerminatedNo Results AvailableDermatologic Complications|Palmar-plantar Erythrodysesthesia|Unspecified Adult Solid Tumor, Protocol SpecificDietary Supplement: pyridoxine hydrochloride|Other: Placebohttps://ClinicalTrials.gov/show/NCT00486213
158415158415A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedNo Results AvailableHerpes GenitalisDrug: ASP2151|Drug: valacyclovir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00486200
158416158416Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL StudyCompletedNo Results AvailableType 2 Diabetes MellitusDrug: rosiglitazone|Drug: metformin or sulfonylureahttps://ClinicalTrials.gov/show/NCT00486187
158417158417Methylene Blue in Sepsis: A Randomized Controlled TrialWithdrawnNo Results AvailableSepsisDrug: methylene bluehttps://ClinicalTrials.gov/show/NCT00486174
158418158418Acylated Ghrelin Response to Acute Exercise in ObesityCompletedNo Results AvailableObesityhttps://ClinicalTrials.gov/show/NCT00486161
158419158419Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS)CompletedNo Results AvailableNutritional SafetyOther: Infant formula (with GOS)https://ClinicalTrials.gov/show/NCT00486148
158420158420Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCompletedNo Results AvailableCancer|LymphomaDrug: XL147 (SAR245408)|Drug: XL147 (SAR245408)https://ClinicalTrials.gov/show/NCT00486135
158421158421Evaluation of Continuous Symptom Treatment of ADHDCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Atomoxetine Hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00486122
158422158422A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection PortCompletedNo Results AvailableType 1 Diabetes|Type 2 DiabetesDevice: I-Port(TM) Injection Porthttps://ClinicalTrials.gov/show/NCT00486109
158423158423Femoral Arterial CannulationTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00486096
158424158424Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHDCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Atomoxetine Hydrochloride|Drug: Methylphenidate Hydrochloridehttps://ClinicalTrials.gov/show/NCT00486083
158425158425Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous ConnectionTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00486070
158426158426Daclizumab Experience in Pediatric Heart TransplantTerminatedNo Results AvailableCongenital Disordershttps://ClinicalTrials.gov/show/NCT00486057
158427158427Evaluating Simvastatin's Potential Role in TherapyCompletedNo Results AvailableAlzheimer DiseaseDrug: Simvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00486044
158428158428Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis StudyCompletedNo Results AvailableInflammatory Bowel Disease|Ulcerative ColitisDrug: Balsalazide Disodiumhttps://ClinicalTrials.gov/show/NCT00486031
158429158429A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)CompletedHas ResultsMacular Edema|Retinal Vein OcclusionDrug: Ranibizumab injection 0.3 mg|Drug: Ranibizumab injection 0.5 mg|Drug: Sham injectionhttps://ClinicalTrials.gov/show/NCT00486018
158430158430Weight Gain Management in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Olanzapine Hydrochloride|Drug: Nizatidine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00486005

* Görseller ve İçerik tekif hakkına sahip olabilir